GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Biotech Acquisition Co (NAS:BIOTU) » Definitions » Loans Receivable

BIOTU (Biotech Acquisition Co) Loans Receivable : $0.00 Mil (As of Sep. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Biotech Acquisition Co Loans Receivable?

Biotech Acquisition Co's Loans Receivable for the quarter that ended in Sep. 2022 was $0.00 Mil.


Biotech Acquisition Co Loans Receivable Historical Data

The historical data trend for Biotech Acquisition Co's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotech Acquisition Co Loans Receivable Chart

Biotech Acquisition Co Annual Data
Trend Dec20 Dec21
Loans Receivable
- -

Biotech Acquisition Co Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Loans Receivable Get a 7-Day Free Trial Premium Member Only - - - - -

Biotech Acquisition Co Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


Biotech Acquisition Co Loans Receivable Related Terms

Thank you for viewing the detailed overview of Biotech Acquisition Co's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotech Acquisition Co Business Description

Traded in Other Exchanges
N/A
Address
545 West 25th Street, 20th Floor, New York, NY, USA, 10001
Website
Biotech Acquisition Co is a blank check company.
Executives
Albert F Hummel director, officer: Chief Investment Officer PO BOX 3407, RANCHO SANTA FE CA 92067
Biotech Sponsor Llc 10 percent owner 545 W. 25TH ST., 20TH FLOOR, NEW YORK NY 10001
Bruno Montanari director 545 WEST 25TH STREET, 20TH FLOOR, NEW YORK NY 10001
Ivan Jarry officer: Chief Operating Officer 545 WEST 25TH STREET, 20TH FLOOR, NEW YORK NY 10001
Paul Bernard director 545 WEST 25TH STREET 20TH FL, NEW YORK NY 10001
Aaron Kim director 545 WEST 25TH STREET 20TH FL, NEW YORK NY 10001
Michael Schleifer director, 10 percent owner, officer: Chief Executive Officer 545 WEST 25TH STREET 20TH FLOOR, NEW YORK NY 10001
Thomas Fratacci officer: CFO & Treasurer 545 WEST 25TH STREET, 20TH FLOOR, NEW YORK NY 10001

Biotech Acquisition Co Headlines

From GuruFocus